Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Madharry who wrote (20899)	3/17/2005 9:31:37 AM
From: Bob Rudd	Read Replies (1) \| Respond to of 78717

Madharry wrote: <<Its like the whole industry has been taken out and shot.>>It's become clear to investors that even with established drugs, they're doing 'Riverdance' thru a minefield. Drugs under development are even more of a crapshoot. Instead of rationally weighing risk/reward for the use a drug, they're taken off the market or slapped with dire warnings that physicians dare not ignore [malpractice]. The FDA is taking big heat over the cox-2's and other flubs, so scrutiny and caution [read higher approval risk & cost] is all but certain. Under these circumstances, it's understandable that investors are demanding higher risk premiums.